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Abstract
OBJECTIVE: Research that seeks to enroll noncompetent patients with Alzheimer’s disease without
presenting any potential benefit to participants is the source of substantial ethical controversy. The authors
used hypothetical Alzheimer’s disease studies that included either a blood draw or a blood draw and lumbar
puncture to explore older persons’ attitudes on this question.
METHOD: Face-to-face interviews were conducted with 538 persons age 65 and older. Questions explored
participants’ understanding of research concepts, their views on enrolling persons with Alzheimer’s disease in
research, and their preferences regarding having a proxy decision maker, granting advance consent, and
granting their proxy leeway to override the participant’s decision. Additional questions assessed altruism,
trust, value for research, and perceptions of Alzheimer’s disease.
RESULTS: The majority (83%) were willing to grant advance consent to a blood draw study, and nearly half
(48%) to a blood draw plus lumbar puncture study. Most (96%) were willing to identify a proxy for research
decision making, and most were willing to grant their proxy leeway over their advance consent: 81% for the
blood draw study and 70% for the blood draw plus lumbar puncture study. Combining the preferences for
advance consent and leeway, the proportion who would permit being enrolled in the blood draw and lumbar
puncture studies, respectively, were 92% and 75%. Multivariate models showed that willingness to be enrolled
in research was most strongly associated with a favorable attitude toward biomedical research.
CONCLUSIONS: Older adults generally support enrolling noncompetent persons with Alzheimer’s disease
into research that does not present a benefit to subjects. Willingness to grant their proxy leeway over advance
consent and a favorable attitude about biomedical research substantially explain this willingness.
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Abstract. 
 
Objective:  Since research that enrolls noncompetent patients with Alzheimers disease 
and does not present potential benefit to subjects is the source of substantial ethical 
controversy, we assessed willingness to have a proxy for research decision making, and, 
for each of two Alzheimers disease biomarker studies (minimal risk blood draw and a 
greater than minimal risk blood draw and lumbar puncture), willingness to grant an 
advance consent, and willingness to grant a proxy leeway over advance consent.  
 
Methods: Face to face survey of 538 persons 65 and over who resided in the Southeastern 
Pennsylvania region  
 
Results: The majority 83% (445/538) granted advance consent to a blood draw study and 
nearly half to a blood draw plus lumbar puncture 259 (48%). Most persons (96%) were 
willing to identify a proxy for research decision making and most were willing to grant 
their proxy leeway over their advance consent: blood draw 434 (81%), and 375 (70%) 
blood draw plus lumbar puncture. Combining the preferences for advance consent and 
leeway, the proportion who would permit being enrolled in the blood draw and spinal 
fluid sample studies were, respectively, 92% (497/538) and 75% (404/538). Multi-variate 
models showed that willingness to be enrolled in research was most strongly associated 
with a favorable attitude about biomedical research. 
 
Conclusions: Older adults generally support enrolling noncompetent persons with 
Alzheimers disease into research that does not present a benefit to subjects. Willingness 
to grant their proxy leeway over advance consent and a favorable attitude about 
biomedical research substantially explain this willingness.  
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Dementia, especially dementia caused by Alzheimers disease (AD), is among the 
most serious public health challenges of the coming decades. The rapid aging of the U.S. 
population means that within 50 years the number of people with dementia will increase 
to 12 million.(1) To respond to this challenge, research is needed that often requires the 
participation of subjects who are themselves demented. But ethical norms surrounding 
the protection of human subjects limit vulnerable persons’ participation in research that 
does not offer the prospect of direct medical benefit and presents more than minimal 
risks.(2)  
To address this problem, researchers and ethicists have developed a model of 
proxy consent. Proxy consent allows another individual to provide consent for a subject 
who is not competent to provide informed consent. The ethic to guide proxy consent is a 
substituted judgment: a proxy should decide based on what the patient, if capable, would 
choose.(3) This is especially advocated in research presenting more than minimal risks 
and without a reasonable prospect of benefit to the subject. For this kind of research, 
proposed guidelines require that a noncompetent subject can be enrolled only if the 
subject has executed a previous written directive indicating a willingness to 
participate.(4) 
Unfortunately, studies show only fair agreement between what a proxy thinks a 
patient would decide and what the patient actually decides(5, 6), and one study that found 
some proxies choose the opposite of what the proxies think the now noncompetent 
patient would have wanted.(7)   
Yet, little research has examined the views of people on this controversy. Studies 
suggest that adults may support enrolling noncompetent persons with AD into research 
using proxies. Most importantly, people may be willing to grant their proxy discretion, or 
leeway, to decide what the proxy thinks is best, even if that proxy’s decision is opposite 
to what the person would want.(8-10) However, these studies have focused on the views 
of persons already enrolled in research about protocols that have the potential to benefit 
subjects.  
No study has examined views of older adults on the degree of leeway they would 
give their proxy to enroll them in AD research that does not present a reasonable prospect 
of benefit. In addition, no study has verified that respondents understand core concepts 
Proxy preferences  Page 4. 
about research, proxy decision making, and research risk. Hence, the available data may 
come from respondents who do not have an adequate understanding of the ethical 
issues.(11) These are complex concepts that can be especially difficult to convey because 
of the necessity that they be framed as future, hypothetical possibilities. Finally, we do 
not know the characteristics of people who are willing or not willing to allow proxy 
consent for research that enrolls noncompetent subjects. This is especially important for 
populations who have historically suffered undue burden in research and therefore may 
mistrust research, such as African-Americans.(12) 
Until we better understand whether people are willing to participate in non-
beneficial research that enrolls persons with AD and why they are willing, policymakers 
cannot develop research ethics policies that respect the values of the people they are 
designed to protect and, in turn, resolve the controversy that has some states and 
institutional review boards substantially limiting the practice of proxy consent for 
research.(13-15) This is especially important because the Office of Human Research 
Protections, the Federal office that writes and enforces human subjects research 
protections, has a working group engaged in determining whether regulations are needed 
for research that enrolls persons with impairments in their decisional capacity.(16)  
The purpose of this study was to discover whether older adults support enrolling 
noncompetent persons with AD into research that does not benefit the subjects. We 
focused on persons 65 and over because age is one of the chief risk factors for 
progressive cognitive impairment and we focused on AD because it is among the most 
common causes of late-life cognitive impairment and there is an urgent need to identify 
biological markers of the disease in blood and spinal fluid. Our survey sought to 
determine whether older adults would want to be enrolled in non-beneficial AD research 
if they themselves had AD and were unable to give an informed consent. We also sought 
to identify the demographic and attitudinal characteristics of persons who support this 
practice.  
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Methods. 
Participants: Eligible participants were residents of the Southeastern Pennsylvania 
region over 65; understood spoken English; could read 14 point font text or, if visually 
impaired, followed a verbal reading of survey text; and provided verbal informed 
consent. Participants were recruited from three clinics (the Philadelphia VA, a university 
urban geriatrics practice, and a university suburban internal medicine practice) and a 
Philadelphia city senior center.  
Measurements: We performed a cross-sectional, 45 to 60 minute face-to-face 
interview consisting of fixed-choice and open ended questions. The interview consisted 
of three parts and incorporated periodic reviews of responses to assure participants 
understood the implications of their choices. 
The first part of the interview assessed understanding of basic research concepts 
(the proxy role, making plans for the future, research, different kinds of benefits, and 
informed consent) by assessing comprehension of a story read to participants. The 
vignette describes a woman’s attitudes about research and how, at a later time, she 
develops AD and is recruited for a study. To assess participant understanding and 
reasoning about the story’s core points, the interviewer asked a set of questions, such as 
“Can you tell me in your own words what is research?” and “Who can make the decision 
whether Mrs. Adams should join this research study?” These questions were based on our 
previous research using the MacCAT-T to assess decision making ability of persons with 
AD and their caregivers(10, 17, 18) and serious illness.(19, 20) 
The second part was a survey of participants’ views about research that enrolls 
persons with AD. Only participants who showed adequate understanding of core concepts 
continued to part two. At the beginning of part two, they were asked if they would be 
willing to have a proxy for research decisions:  
 
Suppose that in the future you had Alzheimers disease and you were unable to make decisions 
about joining a research study. Would you want someone else to serve in the role that Mr. Adams 
did and make decisions for you about enrolling in research? 
 
Next, they were presented in random order one of two studies to develop diagnostic tests 
for biomarkers of AD: (1) a minimal risk study that involved a blood draw, and (2) a 
Proxy preferences  Page 6. 
greater than minimal risk study that involved a blood draw plus a lumbar puncture to 
gather spinal fluid. For each study, the interviewer verified the participant understood the 
risks and benefits of the study and then asked their advance consent:  
 
Suppose that in the future, you had Alzheimers disease and you were in the physical and mental 
state Mrs. Adams was in. Would you say that you would want to participate or not want to 
participate?  
 
Participants who had designated a proxy were asked whether they would grant proxy 
leeway to override the participant’s advance consent. The question was tailored to fit the 
participant’s preference for a proxy and their advance consent. The following shows the 
question asked to a participant who selected his daughter as proxy and declined to grant 
an advance consent to the lumbar puncture: 
 
How much leeway should your daughter have in over riding your choice and instead enroll you in 
the study? By “leeway” I mean your daughter should exercise freedom to choose what she thinks 
is best rather than follow your instructions you just told me about. Would you say she should have 
no leeway or at least some leeway? 
 
Implications of participants’ responses about granting leeway were reviewed, in 
particular, that leeway could override their advance consent. Participants could then 
change answers, if desired.  
Part three measured relevant attitudes and collected demographic information.   
Altruism. We used the 8 item Social Responsibility Scale(21) (higher scores 
indicating a greater degree of social responsibility). We also measured two single item 
measures of behaviors plausibly associated with altruism to science and healthcare: 
“Have you signed up to be an organ donor?” and “Have you signed up to donate your 
body to science?” We selected these two behaviors as they are topically related to the 
decision to be in research and they are readily reported and ascertained by family.  
Trust. We used the 10 item Health Care System Distrust scale(22) (higher scores 
indicating more trust).  
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Value of research. Attitudes about research were assessed using the Research 
Attitudes Questionnaire, an 11-item measure that assesses how favorably or unfavorably 
one views biomedical research (higher scores indicating more favorable views).(23) 
Perception of AD. We used the Perceived Threat of Alzheimers Disease Scale(24) 
(higher scores indicating greater perceived threat) and one single item measure of 
familiarity with AD: “Have you been or are you now close to someone who has 
Alzheimers Disease?”   
Social and demographic characteristics: We collected participants’ age, gender, 
ethnicity, self-identified racial identity, highest grade of school, financial burden 
measured as how finances work out at the end of the month(25), number of living 
children, marital status, and whether they worked in medicine or science. 
Data analyses: Primary endpoint was the participants’ willingness to participate in 
research that enrolled persons with AD who were not capable of consent under each of 
two research risk conditions. We operationalized this as a dichotomous variable called 
“willing to participate.” 
For each of the research conditions, we defined persons not willing to participate 
as a person who did not want a proxy for research and did not grant an advance consent, 
or a person who did want a proxy, did not grant an advance consent, and did not grant 
their proxy leeway over that advance directive. All other persons were defined as willing 
to participate because the net effect of their preferences was willingness to be enrolled. 
For example, a person was willing to participate if their advance consent for the greater 
than minimal risk spinal fluid sample study was “would not want to enroll” but that 
person had been willing to appoint a proxy and to grant proxy leeway over this decision. 
We used logistic regression to examine associations between participant 
characteristics and willingness to allow proxy consent for each research risk condition. 
The binary participation outcome for both high and low risk was analyzed in Stata 
version 10 using a logistic regression model estimated with generalized estimating 
equations (GEE).(26) Accordingly, standard errors of effect estimates were obtained with 
the sandwich variance estimator to adjust for correlated high and low risk observations. 
We did not include order of scenario presentation in the models because it was not 
conceptually a confounder on the effects of interest with willingness to participate. 
Proxy preferences  Page 8. 
Moreover, the interaction of order of presentation with scenario was a not significant 
(p=0.25). Multivariate GEE models were used to evaluate whether self-reported minority 
status impacts willingness to enroll above and beyond other demographic and attitudinal 
co-variates, as some studies suggest race and attitudes about research may influence 
willingness.(12) 
Scale scores missing less than 20% of items were pro-rated; missing items were 
assigned the average value of non-missing items and added to the scale. Participants with 
any individual scale having greater than 20% missing items were not included. 
Human subjects protections: After description of the study to subjects, verbal 
informed consent was obtained to participate in this institutional review board approved 
research. Participants received a $20 gift certificate to compensate for time and effort.  
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Results. 
Participant characteristics: As shown in figure 1, 598 of eligible persons agreed to 
an interview (57%). Women were more likely than men to participate (61% versus 53%, 
chi
2
=7.8, p=0.005), but no differences existed in the race of participants versus non-
participants. Among participants, 93% passed the core concepts assessment. After 
removing 20 participants who did not complete all co-variate scales, the final sample 
consisted of 538 participants. Comparing those 20 removed to the remaining participants 
showed no significant differences in the outcome measures, attitudes or demographics. 
Data were collected from December 2005 to December 2007. 
Table 1 summarizes demographic and attitudinal characteristics. One-third (37%) 
were African-American, 59% female, 38% had no more than 12 years of education, and 
more than one-quarter (29%) reported either just enough or not enough money at the end 
of the month.   
Willingness to be enrolled in AD research that does not present benefit to the 
subjects: Table 2 shows that most 517 (96%) people were willing to designate a proxy for 
research decision making (one person wanted a proxy for the greater than minimal risk 
study but not for the minimal risk study). The majority 445 (83%) granted advance 
consent to a blood draw study and nearly half to a blood draw plus lumbar puncture 259 
(48%). For both research risk conditions, most persons were willing to grant leeway over 
advance consent: blood draw study 434 (81%), and 375 (70%) lumbar puncture study.  
When combining preferences for advance consent and, in the case of persons who 
wanted a proxy, whether they would grant the proxy leeway, we found that 497/538 
(92%) had preferences that would allow enrollment in the blood draw study and 404/538 
(75%) in the lumbar puncture study. 
Participants’ willingness to grant proxy leeway over their advance consent 
substantially contributed to this willingness. Without including participants decision to 
grant their proxy leeway over their advance consent, the proportion whose preferences 
suggest that they would to willing to be enrolled in the lumbar puncture study would have 
decreased from 75% to 52% and the proportion for the blood draw study would have 
decreased from 92% to 83%.  
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Characteristics associated with supporting participation in research that does not 
present benefit to the subjects: Table 3 shows that in both research risk conditions, 
willingness to be enrolled was associated with higher scores on the social responsibility 
scale (minimal risk OR=1.18, 95% CI 1.07 to 1.29, p=0.001; greater than minimal risk 
OR=1.06, 95% CI 1.00 to 1.12, p=0.04), trust in the health care system (minimal risk 
OR=1.10, 95% CI 1.03 to 1.18, p=0.005; greater than minimal risk OR=1.09, 95% CI 
1.05 to 1.14, p<0.001) and favorable attitudes about research (minimal risk OR=1.27, 
95% CI 1.17 to 1.38, p<0.001; greater than minimal risk OR=1.18, 95% CI 1.12 to 1.24, 
p<0.001). In addition, participants who self-reported behaviors associated with these 
attitudes were more willing to permit proxy consent for research that does not present a 
benefit, specifically, persons who reported they were organ donors (minimal risk 
OR=6.28, 95% CI 2.20 to 17.90, p=0.001; greater than minimal risk OR=2.65, 95% CI 
1.69 to 4.16, p<0.001) and, in the case of greater than minimal risk research, had donated 
their body to science (OR=3.28, 95% CI 1.15 to 9.37, p=0.03).  
We did not find a relationship between support for proxy consent and the 
perceived threat of AD, being close to someone with AD, or a history of working in the 
medical or scientific fields. 
Demographic characteristics associated with willingness to be enrolled in research 
with proxy consent varied depending upon degree of research risk. Persons who chose a 
spouse or partner as their research proxy (OR=4.20, 95% CI 1.62 to 10.88, p=0.003), 
reported more years of education (OR=1.11, 95% CI 1.01 to 1.22, p=0.03), or reported 
less financial burden (OR=0.56, 95% CI 0.36 to 0.88, p=0.01) were more willing to be 
enrolled in the minimal risk research, but these associations were not seen in the greater 
than minimal risk condition. Persons who reported being a racial minority were less 
willing to be enrolled in greater than minimal risk research (OR=0.59, 95% CI 0.40 to 
0.87, p=0.008). 
Multivariate analyses to examine the relative effects of attitudes and 
characteristics found that, in the greater than minimal risk scenario, minority status was 
the only demographic associated with a reduced willingness to participate. Other 
demographic measures (years of education, financial burden, and gender) did not 
attenuate this association (OR=0.63, 95% CI 0.42 to 0.96, p=0.03). Minority status was 
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not significant in the minimal risk scenario, though the effect was in the same direction 
(OR=0.58, 95% CI 0.31 to 1.10, p=0.09).  
Similarly, favorable attitudes about research was the only attitudinal characteristic 
associated with willingness to participate in multivariate models, and the addition of 
other attitudinal variables (Social Responsibility, Health Care System Distrust, 
Alzheimer’s Disease Perceived Threat) did not attenuate this effect in either the high risk 
(OR=1.19, CI 1.13 to 1.27, p<0.001) or low risk (OR=1.19, CI 1.13 to 1.27, p<0.001) 
scenarios.  
Models examining the combined effect of the Research Attitude Questionnaire 
and minority status for the greater than minimal risk scenario showed the effect for 
minority status disappear (Research Attitude Questionnaire OR=1.20, CI 1.14-1.26, 
p<0.001; minority status OR=0.84, CI 0.55-1.28, p=0.42). 
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Discussion. 
Our results suggest that older adults support enrolling noncompetent patients with 
AD in non-beneficial research. Even in the greater than minimal risk lumbar puncture 
study, three-quarters of participants had preferences permiting their enrollment in 
research if they had AD and could not provide informed consent. We discuss four key 
findings. 
It is notable that  preference to grant a proxy leeway over advance consent 
substantially contributed to willingness to be enrolled. These results suggest that many 
people who do not want to participate in certain kinds of medical research are still willing 
to appoint a proxy with the ability to override that decision. These results are supported 
by a study of persons with AD showing that preferences about granting proxy leeway 
over an advance consent decision are a critical element of how elderly people formulate 
advance planning preferences.(8)  
The second key finding is that participants’ favorable attitudes about research, 
sense of social responsibility and trust in the health care system were associated with 
support for proxy consent, but experiences with AD were not. This result expands the 
finding among a postal survey of elderly persons that the strongest association with 
support for proxy consent for research was favorable attitudes about research.(23) Neither 
that study, nor a telephone survey of caregivers of persons with AD,(9) found that 
attitudes about AD were associated with support for proxy consent. Collectively, these 
results suggest that overarching values such as trust and altruism shape attitudes about the 
ethics of research that enrolls noncompetent subjects, not specific views on the disease 
under study. 
Third, persons who reported being a racial minority were less likely to support 
enrolling noncompetent persons in greater than minimal risk research. Notably, this 
association was independent of age, education and financial burden, yet dropped out of 
models that adjusted for attitudes about research. These results suggest that favorable 
attitudes about research, more so than trust or altruism, largely explain racial differences 
in support for research that enrolls noncompetent subjects. 
Finally, most participants (93%) generally understood the core concepts of the 
proxy role, making plans for the future, research, different kinds of benefits in research, 
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and informed consent. This finding is encouraging. It suggests that older adults can 
participate in research advance planning.  
The strengths of this study are that all respondents demonstrated adequate 
understanding of the core concepts required for informed research participation, and the 
interview was designed to assure that participants understood the consequences of their 
preferences. Previous research in advance planning has been limed by failure to assure 
that participants understood the complex future oriented issues at stake.(11) Second, the 
sample reflected the ethnic diversity of the Philadelphia region and we measured relevant 
attitudes that might explain preferences about proxy consent. 
Limitations include the focus on research to develop biomarkers for AD. Hence, 
results may not apply to research involving other kinds of conditions, such as critical 
illness. In addition, our sample was limited to persons at plausible risk for developing 
AD: persons 65 and older. While this design choice respected the need to have a real 
world scenario, it is entirely possible that a younger cohort would have different views on 
proxy consent. Future studies should investigate views of persons at risk for critical 
illness and younger persons. 
At present, research -- especially greater than minimal risk research -- that seeks 
to enroll noncompetent persons with proxy consent is the source of substantial 
controversy. Some states and institutions restrict the practice;(27) federal research 
regulations offer no guidance on the matter; and past efforts to develop guidance have 
collapsed.(4, 28) The Office of Human Research Protections, the Federal office that 
writes and enforces human subjects research protections, has a working group engaged in 
determining whether regulations are needed for research that enrolls persons with 
impairments in decision making capacity.(16)  
Our results have important implications on that effort. They suggest that, in 
general, elderly people support enrolling noncompetent patients in research that studies 
the patients’ disease even though that research will not benefit the subjects’ health and 
well being but instead, the research might benefit others. This support reflects a 
willingness to grant a proxy leeway over an advance consent. Hence, policies that require 
a proxy to exercise a strict substituted judgment based upon past consent preference do 
not respect how people want their proxies to make decisions. It also suggests that 
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researchers and their funders focus on how their behaviors shape people’s attitudes about 
research. 
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Tables. 
Table 1. Subject Characteristics (N = 538). 
Demographics  
Gender 
     Male 
     Female 
 
222 (41.3%) 
316 (58.7%) 
Race 
     Caucasian 
     African-American 
     Asian 
     American Indian 
     Pacific Islander 
 
329 (61.2%) 
198 (36.8%) 
9 (1.7%) 
1 (<1%) 
1(<1%) 
Ethnicity 
     Latino 
     Not Latino 
 
7 (1.3%) 
531 (98.7%) 
Living Situation 
     Married 
     Widowed 
     Living with someone else 
     Divorced 
     Single 
 
255 (47.4%) 
160 (29.7%) 
15 (2.8%) 
56 (10.4%) 
52 (9.7%) 
Financial Burden 
     Some money left over 
     Just enough to make ends meet 
     Not enough to make ends meet 
 
383 (71.2%) 
119 (22.1%) 
36 (6.7%) 
Age in years 76.8 ± 6.7 
(65-96) 
Years of education  14.5 ± 3.4  
(4-21) 
Attitudinal Characteristics  
Social Responsibility Scale (8-40) 31.7 ± 3.7 
(22-40) 
Is an organ donor 
     Yes 
      No 
 
205 (38.1%) 
333 (61.9%) 
Has donated body to science 
     Yes 
      No 
 
41(7.6%) 
497 (92.4%) 
Health Care System Distrust Scale (10-50) 
 
33.0 ± 4.8 
(19-50) 
Has/had a job in medical or scientific field 
     Yes 
      No 
 
173 (32.2%) 
365 (67.8%) 
Research Attitudes Questionnaire (11-55) 39.9 ± 4.1 
(23 – 54) 
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Is/was close to someone with Alzheimers Disease 
     Yes             
      No 
 
266 (49.4%) 
272 (50.6%) 
Alzheimer’s Disease Perceived Threat Scale (7-35) 17.2 ± 5.5 
(7-33) 
AD Threat- Likelihood Subscale (2-10) 
 
4.0 ± 1.9 
(2-10) 
AD Threat- Concern Subscale (3-15) 7.2 ± 3.4  
(3-15) 
AD Threat- Consequence Subscale (2-10) 6.1 ± 2.1  
(2-10) 
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Table 2. Willingness to be enrolled in minimal risk and greater than minimal risk research 
if they had Alzheimers Disease and were not capable of informed consent
a
. 
Advance Consent Proxy  No proxy Total 
 No Leeway Leeway   
Minimal risk study: blood draw  
     No 28  
(5.2%) 
52 
(9.7%) 
13 
(2.4%) 
93 
(17.3%) 
     Yes 56 
(10.4%) 
382 
(71.0%) 
7 
(1.3%) 
445 
(82.7%) 
Total 84 
(15.6%) 
434 
(80.7%) 
20 
(3.7%) 
538 
(100%) 
Greater than minimal risk study: blood draw and spinal fluid sample 
     No 115 
(21.4%) 
145 
(27.0%) 
19 
(3.5%) 
279 
(51.9%) 
     Yes 27 
(5.0%) 
230 
(42.7%) 
2 
(0.4%) 
259 
(48.1%) 
Total 142 
(26.4%) 
375 
(69.7%) 
21 
(3.9%) 
538 
(100%) 
a
The proportion of subjects who are not willing to participate is the sum of cells described 
by “ No advance consent/No leeway” and “No advance consent/No proxy”.  
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Table 3. Associations between subjects’ demographics and attitudinal characteristics and 
their willingness to be enrolled in research if they had Alzheimers Disease and were not 
capable of informed consent. 
 Willingness to be enrolled in 
minimal risk study 
Willingness to be enrolled in 
greater than minimal risk study 
Characteristic Odds Ratio
a
(95% CI) 
P-value Odds Ratio 
(95% CI) 
P-value 
Female
 
1.12 
(0.59-2.14) 
0.72 0.80 
(0.54-1.20) 
0.28 
Reports non-white 
race
b 
0.58 
(0.31-1.10) 
0.09 0.59 
(0.40-0.87) 
0.008 
Financial burden 0.56 
(0.36-0.88) 
0.01 0.75 
(0.55-1.01) 
0.06 
Age in years 0.99  
(0.94-1.04) 
0.61 1.00 
(0.97-1.03) 
0.82 
Years of education 1.11 
(1.01-1.22) 
0.03 1.03 
(0.97-1.09) 
0.31 
Social Responsibility 
Scale
c
 
1.18 
(1.07-1.29) 
0.001 1.06 
(1.00-1.12) 
0.036 
Is an organ donor 6.28 
(2.20-17.90) 
0.001 2.65 
(1.69-4.16) 
<0.001 
Has donated body to 
science 
1.66 
(0.39-7.14) 
0.50 3.28 
(1.15-9.37) 
0.03 
Health Care System 
Distrust Scale
d 
1.10 
(1.03-1.18) 
0.005 1.09 
(1.05-1.14) 
<0.001 
Research Attitudes 
Questionnaire
e 
1.27 
(1.17-1.38) 
<0.001 1.18 
(1.12-1.24) 
<0.001 
Has/had a job in 
medical or scientific 
field 
1.32 
(.64-2.70) 
0.45 1.15 
(.75-1.76) 
0.51 
Is/was close to 
someone with 
Alzheimers Disease 
0.83  
(0.44-1.58) 
0.58 1.01 
(0.68-1.49) 
0.96 
Perceived Threat of 
Alzheimers Disease 
Scale
f 
1.01 
(0.95-1.07) 
0.83 1.02 
(0.99-1.06) 
0.25 
Chose spouse as 
research proxy 
4.20 
(1.62-10.88) 
0.003 1.13  
(0.75-1.71) 
0.56 
a
OR > 1 indicates a characteristic that is associated with willingness to be enrolled.  
b
African American (n=198), Asian (n=9), American Indian (n=1), Pacific Islander (n=1).  
c
Higher scores indicate more altruism. 
d
Higher scores indicate more trust in healthcare system. 
e
Higher scores indicate more favorable views towards biomedical research. 
f
Higher score indicates higher perceived threat of Alzheimers Disease. 
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Figures. 
Figure 1. Disposition of subject recruitment. 
1390 Contacted 
1047 Eligible  343 Ineligible 
449 Refused  
(42.9%) 
598 Consented 
(57.1%) 
40 Unable to complete 
interview (6.7%) 
558 Completed interview 
(93.3%) 
20 Missing Data 
(3.6%) 
538 Included in analyses 
(96.4%) 
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Greater than minimal risk study description. 
 study to develop a new test to diagnose Alzheimers Disease 
hat is the purpose of this study?
 
A
 
W  
he purpose is to develop a new test to detect Alzheimers Disease. The study will 
ompare the protein levels in the blood and spinal fluid of people who have Alzheimers 
isease with people who do not have Alzheimers. These proteins are released by nerve 
ells as they die. These proteins may be high in persons with Alzheimers, and they may 
e low in persons without Alzheimers.  
ho is being enrolled in this study?
T
c
D
c
b
 
W  
he researchers are inviting two kinds of people to join this study: people who have 
lzheimers disease and people who do not.  
hat will happen to people who join this study?
T
A
 
W  
spoons of blood and a 
mbar puncture. A lumbar puncture is also called a spinal tap. 
ample 
 
al canal in the lower back. This is done in a 
lace that is well below the end of the spinal cord. Two tablespoons of spinal fluid are 
This study will take about three hours. 
 
People who join this study will have a single blood draw of 2 table
lu
 
A lumbar puncture is a routine medical procedure. It allows the physician to get a s
of fluid that surrounds the brain and spinal cord. The procedure is done at a Clinical 
Research Center. An injection of local anesthetic is put in the skin and the muscle around
the areas of the lower back. When the area is numb, the physician inserts a thin needle 
through the skin and muscle into the spin
p
removed.  
 
What are the risks of this research? 
The risks of a spinal tap are pain at the site of the needle puncture, a slight risk of 
al anesthetic, and a headache. Headache 
ave the procedure. It usually lasts for 1 to two 
ays. In unusual cases, headaches may be moderately severe and last for several days. 
he risks of the blood test are pain and discomfort at the site of the needle. 
infection, a rare risk of allergic reaction to the loc
occurs in about 3% of the people who h
d
These headaches may be treated. 
 
T
 
What are the benefits of this research? 
People who join this study will not benefit. The results of this research may help develop 
a test to make an accurate and early diagnosis of Alzheimers disease.  
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Minimal risk study description. 
 
A study to develop a new test to diagnose Alzheimers Disease 
 
What is the purpose of this study? 
The purpose is to develop a new test to detect Alzheimers Disease. The study will 
ompare the protein levels in the blood of people who have Alzheimers with people who 
ie. These 
roteins may be high in persons with Alzheimers, and they may be low in persons 
c
do not have Alzheimers. These proteins are released by nerve cells as they d
p
without Alzheimers.  
 
Who is being enrolled in this study? 
The researchers are inviting two kinds of people to join this study: people who have 
lzheimers disease and people who do not.  
hat will happen to people who join this study?
A
 
W  
his study will take about 15 minutes. 
eople who join this study will have a single blood draw of 2 tablespoons of blood. 
hat are the risks of this research?
T
 
P
 
W  
and discomfort at the site of the needle. The risks of the blood test are pain 
 
What are the benefits of this research? 
People who join this study will not benefit. The results of this research may help develop 
a test to make an accurate and early diagnosis of Alzheimers disease.  
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uestions to assess study comprehension. 
o you have any questions about this? 
nderstands the risks of the study: "Can you tell me the risks of this study?" 
nderstands the benefits of the study: "Can you tell me the benefits of this study?" 
Q
 
D
 
U
 
U
 
